Intech Biopharm currently focuses mainly on developing drugs for obstructive airway diseases such as bronchial asthma and chronic obstructive pulmonary disease (COPD). By owning the superior HFA MDI platforms with facilities at the high level as EMA and US FDA standard, we have received a number of governmental grants and awards, and moreover, important patents in this field. Our further plan involves the development of drugs for treating cancers and other top-listing diseases affecting people globally.
Our strengths include proficient manufacturing, professional teams, balanced finances and strong marketing strategies. Our core value are "Innovation", "Quality", "Professional", and "Care". After years of growth and development, we have transformed from a startup company to a robust organization with high profiting potential. We will continue to accomplish our goal: improving the welfare of the people.